Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term cytokine exposure remodels the methylome and transcriptome of recessive dystrophic epidermolysis bullosa keratinocytes - a bioinformatic analysis.

Frontiers in cell and developmental biology·2026
Same author

Why promising ATMPs fail to reach patients: a qualitative stakeholder-informed analysis of cell therapy access in Europe.

Journal of translational medicine·2026
Same author

Base-edited skin equivalents: A promising ex vivo approach for recessive dystrophic epidermolysis bullosa.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.

The Journal of investigative dermatology·2025
Same author

Patient-reported outcomes during pregnancy and delivery in epidermolysis bullosa.

BMC pregnancy and childbirth·2025
Same author

Light-Induced Degradation of Tamoxifen in Liquid Formulations: Multivariate Kinetic Profiling, Stabilization Strategies, and Estrogen Receptor Binding.

ACS omega·2025

Related Experiment Video

Updated: Jan 5, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K

Toward Combined Cell and Gene Therapy for Genodermatoses.

Laura De Rosa1, Maria Carmela Latella1, Alessia Secone Seconetti1

  • 1Holostem Terapie Avanzate S.r.l., Center for Regenerative Medicine "Stefano Ferrari," 41125 Modena, Italy.

Cold Spring Harbor Perspectives in Biology
|October 27, 2019
PubMed
Summary

Gene and cell therapies offer hope for monogenic skin diseases. Future treatments will likely combine approaches tailored to individual patients for curative genodermatosis therapies.

More Related Videos

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.5K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

915

Related Experiment Videos

Last Updated: Jan 5, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.5K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

915

Area of Science:

  • Dermatology
  • Genetics
  • Regenerative Medicine

Background:

  • Over 200 monogenic skin diseases (genodermatoses) exist, often with severe impacts.
  • Current treatments for genodermatoses often fail to provide long-lasting or curative solutions.
  • Significant unmet medical needs drive the search for advanced therapeutic strategies.

Purpose of the Study:

  • To review combined cell and gene therapy strategies for genodermatoses that have reached clinical application.
  • To explore future patient-oriented therapeutic approaches for rare genetic skin disorders.
  • To discuss the challenges and potential of definitive treatments for genodermatoses.

Main Methods:

  • Literature review focusing on clinical studies of combined cell and gene therapies for genodermatoses.
  • Analysis of successful and emerging therapeutic strategies.
  • Synthesis of current knowledge to project future treatment paradigms.

Main Results:

  • A limited number of combined cell and gene therapy strategies have successfully entered clinical practice for genodermatoses.
  • These clinical successes provide a foundation for future therapeutic development.
  • The review highlights the complexity and multi-faceted nature of treating genetic skin conditions.

Conclusions:

  • Future genodermatosis treatments will likely involve personalized, patient-specific strategies.
  • A combination of advanced therapies, including cell and gene editing, will be crucial for curative outcomes.
  • Overcoming challenges in treating genodermatoses requires innovative and integrated therapeutic approaches.